Current hypotheses for this increased prevalence of deadly colorectal cancers in young people are largely focused on broad-scale changes that have taken place in the past 30 years, including lifestyle, diet, and even microplastics.
But Cercek added: « What’s happening ‘big picture’ is alarming. But it’s super important to acknowledge that survivorship for a young adult with colorectal cancer is life-changing. It’s incredibly difficult and can be incredibly taxing from an emotional, physical and financial standpoint.
« The more that we can diagnose early, the better it will be for our patients. »
If you’ve been affected by any of these issues and want to speak to someone in confidence, contact the American Cancer Society on 1-800-227-2345 or via their live chat feature, available 24/7 every day of the year.
A study has found that using GLP-1 drugs could reduce the rates of death in certain cancer patients.
Almost 12 percent of Americans have used the medication, as per RAND.
The injectable drugs works by mimicking the hormone glucagon-like peptide-1, which helps control blood sugar and appetite.
Wegovy, Zepbound and Saxenda are all FDA-approved prescription medications for weight loss in the United States.
Then there’s Ozempic, which belongs to the same family of drugs but isn’t signed off for weight loss; instead, it’s used to manage type 2 diabetes.
Now, new research from the University of California San Diego suggests these drugs can lower death rates in patients with a type of cancer surging in young people.
